Laboratory Medicine ›› 2018, Vol. 33 ›› Issue (11): 1049-1052.DOI: 10.3969/j.issn.1673-8640.2018.011.017
• Orginal Article • Previous Articles Next Articles
CHEN Jia1, WANG Jian2, JIN Wei1, CHEN Xudong1, HU Xiaobo1()
Received:
2018-04-10
Online:
2018-11-30
Published:
2018-11-28
CLC Number:
CHEN Jia, WANG Jian, JIN Wei, CHEN Xudong, HU Xiaobo. Research progress of exosomal miRNA in pancreatic cancer[J]. Laboratory Medicine, 2018, 33(11): 1049-1052.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2018.011.017
[1] | SIEGEL R L,MILLER K D,JEMAL A.Cancer statistics,2017[J]. CA Cancer J Clin,2017,67(1):7-30. |
[2] | KAMISAWA T,WOOD L D,ITOI T,et al.Pancreatic cancer[J]. Lancet,2016,388(10039):73-85. |
[3] | ZHOU B,XU J W,CHENG Y G,et al.Early detection of pancreatic cancer:where are we now and where are we going?[J]. Int J Cancer,2017,141(2):231-241. |
[4] | NATH S,MANDAL C,CHATTERJEE U,et al.Association of cytosolic sialidase Neu2 with plasma membrane enhances Fas-mediated apoptosis by impairing PI3K-Akt/m TOR-mediated pathway in pancreatic cancer cells[J]. Cell Death Dis,2018,9(2):210. |
[5] | GOMEZ-RUBIO P,ZOCK J P,RAVA M,et al.Reduced risk of pancreatic cancer associated with asthma and nasal allergies[J]. Gut,2017,66(2):314-322. |
[6] | ARMSTRONG E A,BEAL E W,CHAKEDIS J,et al.Exosomes in pancreatic cancer:from early detection to treatment[J]. J Gastrointest Surg,2018,22(4):737-750. |
[7] | QIU J,YANG G,FENG M,et al.Extracellular vesicles as mediators of the progression and chemoresistance of pancreatic cancer and their potential clinical applications[J]. Mol Cancer,2018, 17(1):2. |
[8] | ZHAO C,GAO F,WENG S,et al.Pancreatic cancer and associated exosomes[J]. Cancer Biomark,2017,20(4):357-367. |
[9] | JIN H,WU Y,TAN X.The role of pancreatic cancer-derived exosomes in cancer progress and their potential application as biomarkers[J]. Clin Transl Oncol,2017,19(8):921-930. |
[10] | PATEL G K,PATTON M C,SINGH S,et al.Pancreatic cancer exosomes:shedding off for a meaningful journey[J]. Pancreat Disord Ther,2016,6(2):e148. |
[11] | ROBINSON S M,FAN L,WHITE S A,et al.The role of exosomes in the pathogenesis of pancreatic ductal adenocarcinoma[J]. Int J Biochem Cell Biol,2016,75:131-139. |
[12] | SUN W,LUO J D,JIANG H,et al.Tumor exosomes:a double-edged sword in cancer therapy[J]. Acta Pharmacol Sin,2018,39(4):534-541. |
[13] | ZAMANIAN M,FRASER L M,AGBEDANU P N,et al.Release of small RNA-containing exosome- like vesicles from the human filarial parasite brugia malayi[J]. PLoS Negl Trop Dis,2015,9(9):e0004069. |
[14] | MILANE L,SINGH A,MATTHEOLABAKIS G,et al.Exosome mediated communication within the tumor microenvironment[J]. J Control Release,2015,219:278-294. |
[15] | DE TORO J,HERSCHLIK L,WALDNER C,et al.Emerging roles of exosomes in normal and pathological conditions:new insights for diagnosis and therapeutic applications[J]. Front Immunol,2015,6:203. |
[16] | SATO-KUWABARA Y,MELO S A,SOARES F A,et al.The fusion of two worlds:noncoding RNAs and extracellular vesicles-diagnostic and therapeutic implications(review)[J]. Int J Oncol,2015,46(1):17-27. |
[17] | TKACH M,THÉRY C. Communication by extracellular vesicles:where we are and where we need to go[J]. Cell,2016,164(6):1226-1232. |
[18] | CAI M,KOLLURU G K,AHMED A.Small molecule,big prospects:microRNA in pregnancy and its complications[J]. J Pregnancy,2017,2017:6972732. |
[19] | AMERES S L,HORWICH M D,HUNG J H,et al.Target RNA-directed trimming and tailing of small silencing RNAs[J]. Science,2010,328(5985):1534-1539. |
[20] | BIDARIMATH M,KHALAJ K,WESSELS J M,et al.MicroRNAs,immune cells and pregnancy[J]. Cell Mol Immunol,2014,11(6):538-547. |
[21] | CATALANOTTO C,COGONI C,ZARDO G. MicroRNA in control of gene expression:an overview of nuclear functions[J]. Int J Mol Sci,2016,17(10):pii:E1712. |
[22] | JONAS S,IZAURRALDE E.Towards a molecular understanding of microRNA-mediated gene silencing[J]. Nat Rev Genet,2015,16(7):421-433. |
[23] | XIAO M,LI J,LI W,et al.MicroRNAs activate gene transcription epigenetically as an enhancer trigger[J]. RNA Biol,2017,14(10):1326-1334. |
[24] | DING G,ZHOU L,QIAN Y,et al.Pancreatic cancer-derived exosomes transfer miRNAs to dendritic cells and inhibit RFXAP expression via miR-212-3p[J]. Oncotarget,2015,6(30):29877-29888. |
[25] | ZHOU M,CHEN J,ZHOU L,et al.Pancreatic cancer derived exosomes regulate the expression of TLR4 in dendritic cells via miR-203[J]. Cell Immunol,2014,292(1-2):65-69. |
[26] | TOMINAGA N,KOSAKA N,ONO M,et al.Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier[J]. Nat Commun,2015,6:6716. |
[27] | LIU Y,LUO F,WANG B,et al.STAT3-regulated exosomal miR-21 promotes angiogenesis and is involved in neoplastic processes of transformed human bronchial epithelial cells[J]. Cancer Lett,2016,370(1):125-135. |
[28] | ZHANG L,ZHANG S,YAO J,et al.Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth[J]. Nature,2015,527(7576):100-104. |
[29] | BASU S,BHATTACHARYYA S N.Insulin-like growth factor-1 prevents miR-122 production in neighbouring cells to curtail its intercellular transfer to ensure proliferation of human hepatoma cells[J]. Nucleic Acids Res,2014,42(11):7170-7185. |
[30] | CHEN D,WU X,XIA M,et al.Upregulated exosomic miR-23b-3p plays regulatory roles in the progression of pancreatic cancer[J]. Oncol Rep,2017,38(4):2182-2188. |
[31] | TAKIKAWA T,MASAMUNE A,YOSHIDA N,et al.Exosomes derived from pancreatic stellate cells:microRNA signature and effects on pancreatic cancer cells[J]. Pancreas,2017,46(1):19-27. |
[32] | MIKAMORI M,YAMADA D,EGUCHI H,et al.MicroRNA-155 controls exosome synthesis and promotes gemcitabine resistance in pancreatic ductal adenocarcinoma[J]. Sci Rep,2017,7:42339. |
[33] | BORSOI C,LEONARD F,LEE Y,et al.Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal adenocarcinoma[J]. Cancer Lett,2017,403:296-304. |
[34] | QUE R,DING G,CHEN J,et al.Analysis of serum exosomal microRNAs and clinicopathologic features of patients with pancreatic adenocarcinoma[J]. World J Surg Oncol,2013,11:219. |
[35] | MADHAVAN B,YUE S,GALLI U,et al.Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity[J]. Int J Cancer,2014,136(11):2616-2627. |
[36] | MACHIDA T,TOMOFUJI T,MARUYAMA T,et al.miR-1246 and miR-4644 in salivary exosome as potential biomarkers for pancreatobiliary tract cancer[J]. Oncol Rep,2016,36(4):2375-2381. |
[1] | CHEN Wenju, ZHOU Yong, XU Jiajia, WANG Pan. Role of serum exosomal miR-23b-3p and miR-4429 in patients with hepatocellular carcinoma [J]. Laboratory Medicine, 2023, 38(7): 624-628. |
[2] | PAN Xin, LÜ Ying, LI Yang, LI Rongguo. Effects of miR-24-3p targeting CHD5 on migration,invasion and radiosensitivity of thyroid cancer cells [J]. Laboratory Medicine, 2023, 38(7): 640-646. |
[3] | WANG Tengfei, CHEN Shan, AN Hebing, ZHOU Lei. Expressions and roles of lncRNA CRNDE and miR-384 in peripheral blood of patients with acute leukemia [J]. Laboratory Medicine, 2023, 38(7): 686-691. |
[4] | ZHANG Ying, JING Lijuan, LI Li. Relationship between the expression of miR-138 in peripheral blood mononuclear cells of hepatitis B virus proliferation in carriers [J]. Laboratory Medicine, 2023, 38(6): 559-562. |
[5] | ZHANG Min, WANG Binyu, CHI Weiqun, LIU Yu. Research progress of exosomal non-coding RNA as biomarkers for disease diagnosis [J]. Laboratory Medicine, 2023, 38(6): 594-598. |
[6] | ZHAO Jing, WANG Pei, LU Dandan, QI Dandan, LI Xuan. Expression levels of serum miR-4443 and TRAF4 in patients with hemorrhagic stroke [J]. Laboratory Medicine, 2023, 38(5): 413-418. |
[7] | LIU Ruili, LI Lanjun, JIA Minlei, WANG Yihui, HAO Weina. Correlation between tumor miR-7-5p and NOVA2 levels and clinical prognosis in cancer tissues of patients with gastric cancer [J]. Laboratory Medicine, 2023, 38(4): 325-329. |
[8] | YUAN Shuang, FENG Lei, GUO Xiaofen, FU Xiaoling, XU Jing, LIU Hongyang. Relation of miR-433 in endometrial cancer tissues and its relationship with chemotherapy sensitivity [J]. Laboratory Medicine, 2023, 38(4): 337-341. |
[9] | CHEN Zhe, ZHANG Ling, LIU Jie, WANG Xia, ZHANG Bin, GAO Binghua. Relationship between serum miR-326 and chemotherapy sensitivity and prognosis in patients with treatment-related hematological malignancy [J]. Laboratory Medicine, 2023, 38(3): 251-256. |
[10] | LIU Chong, ZHANG Jing, LI Sheng, ZHAO Qi. Expressions and correlation of miR-335 and Fra-1 in breast cancer [J]. Laboratory Medicine, 2023, 38(2): 143-147. |
[11] | WU Jiong, HU Jiahua, SHI Meifang, LIU Tao, DAI Jie, LU Xinyi, ZOU Zheng. Research progress of biomarkers of prostate cancer [J]. Laboratory Medicine, 2023, 38(2): 190-195. |
[12] | GAO Jianchao, WANG Sisi, ZHANG Zhisheng, ZHANG Jingli, LI Xiaoxia, MA Ke, FENG Zhilin, ZHOU Haifeng, WANG Zhanhai. Efficacy and prognosis evaluation of neo-adjuvant chemotherapy for breast cancer based on miR-206,miR-125 and miR-21 [J]. Laboratory Medicine, 2023, 38(11): 1062-1068. |
[13] | ZHU Qian, ZHU Lifang, MA Caiyun, YAO Jie. Relation of serum miR-140-5p and PGC-1α mRNA expression with vascular cognitive impairment in acute ischemic stroke patients [J]. Laboratory Medicine, 2023, 38(11): 1069-1074. |
[14] | HUANG Zhongqiang, DAI Di, HOU Tieying, LIN Faquan, LU Zhiming, LIU Xiaoqi, SHEN Minna, WU Jie, ZHANG Pingan, ZHOU Jun, XIAO Yanqun, WANG Hualiang. Multicenter performance evaluation of a 7-microRNA test kit [J]. Laboratory Medicine, 2023, 38(11): 1075-1081. |
[15] | XUE Yaze, HE Jin, TANG Shaojun. Roles of serum miR-150-5p and LTBP-2 determinations in evaluating the condition of acute cerebral infarction patients [J]. Laboratory Medicine, 2023, 38(11): 1082-1086. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||